Literature DB >> 3496848

Effect of broad-spectrum parenteral antibiotics on "colonization resistance" of intestinal microflora of humans.

M Barza, M Giuliano, N V Jacobus, S L Gorbach.   

Abstract

Studies with animals have shown that the normal intestinal microflora protects against colonization by new strains ("colonization resistance") and that this protective effect may be related to the anaerobic component of the microflora. However, colonization resistance has not been shown in humans. We administered cefoxitin, piperacillin, cefoperazone, and aztreonam intravenously to healthy subjects for 9 days and monitored the acquisition of new isolates in the fecal flora. Seven of sixteen antibiotic-treated subjects but none of four untreated controls became colonized by gram-negative bacilli. However, there was no correlation between colonization and the particular drug given or the extent of suppression of anaerobes or of any other component of the fecal microflora. Cefoxitin and piperacillin were associated with the greatest increases in the numbers of drug-resistant bacteria and in fecal beta-lactamase content. The results of this study support the concept that colonization resistance occurs in humans and is diminished by antibiotic administration but fail to support the hypothesis that resistance is related to the anaerobic microflora.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3496848      PMCID: PMC174822          DOI: 10.1128/AAC.31.5.723

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  34 in total

1.  Salmonellosis--a review of some unusual aspects.

Authors:  P H BLACK; L J KUNZ; M N SWARTZ
Journal:  N Engl J Med       Date:  1960-04-28       Impact factor: 91.245

Review 2.  Typhoid fever: pathogenesis and immunologic control.

Authors:  R B Hornick; S E Greisman; T E Woodward; H L DuPont; A T Dawkins; M J Snyder
Journal:  N Engl J Med       Date:  1970-09-24       Impact factor: 91.245

3.  Exacerbation of salmonella enteritis due to ampicillin.

Authors:  S L Rosenthal
Journal:  N Engl J Med       Date:  1969-01-16       Impact factor: 91.245

4.  The effect of hospitalization and antibiotic therapy on the gram-negative fecal flora.

Authors:  H D Rose; J Schreier
Journal:  Am J Med Sci       Date:  1968-04       Impact factor: 2.378

5.  The fate of ingested Pseudomonas aeruginosa in normal persons.

Authors:  A C Buck; E M Cooke
Journal:  J Med Microbiol       Date:  1969-11-04       Impact factor: 2.472

6.  Colonization resistance of the digestive tract in conventional and antibiotic-treated mice.

Authors:  D van der Waaij; J M Berghuis-de Vries
Journal:  J Hyg (Lond)       Date:  1971-09

Review 7.  Preservation of colonization resistance parameters during empiric therapy with aztreonam in the febrile neutropenic patient.

Authors:  T J Louie; H Chubb; E J Bow; J M Conly; G K Harding; E Rayner; M James
Journal:  Rev Infect Dis       Date:  1985 Nov-Dec

8.  Changes in gut flora after cephalexin treatment.

Authors:  H Gaya; P I Adnitt; P Turner
Journal:  Br Med J       Date:  1970-09-12

9.  Inducible type I beta-lactamases of gram-negative bacteria and resistance to beta-lactam antibiotics.

Authors:  N A Curtis; R L Eisenstadt; C Rudd; A J White
Journal:  J Antimicrob Chemother       Date:  1986-01       Impact factor: 5.790

10.  Effect of the normal microbial flora on the resistance of the small intestine to infection.

Authors:  G D Abrams; J E Bishop
Journal:  J Bacteriol       Date:  1966-12       Impact factor: 3.490

View more
  16 in total

1.  Eradication of the commensal intestinal microflora by oral antimicrobials interferes with the host response to lipopolysaccharide.

Authors:  T Umenai; H Hirai; N Shime; T Nakaya; T Asahara; K Nomoto; M Kita; Y Tanaka; J Imanishi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-03-20       Impact factor: 3.267

2.  Modulation of the intestinal flora of mice by treatment with aztreonam and tigemonam.

Authors:  M L van Ogtrop; H F Guiot; H Mattie; E van Strijen; B R Sekh; R van Furth
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

Review 3.  Probiotics and liver disease.

Authors:  Vishal Sharma; Shashank Garg; Sourabh Aggarwal
Journal:  Perm J       Date:  2013

4.  Identification of Bifidobacterium strains by rRNA gene restriction patterns.

Authors:  I Mangin; N Bourget; Y Bouhnik; N Bisetti; J M Simonet; B Decaris
Journal:  Appl Environ Microbiol       Date:  1994-05       Impact factor: 4.792

5.  Characterization of human faecal flora by means of an improved fluoro-morphometrical method.

Authors:  G J Jansen; M H Wilkinson; B Deddens; D van der Waaij
Journal:  Epidemiol Infect       Date:  1993-10       Impact factor: 2.451

Review 6.  Colonization resistance.

Authors:  E J Vollaard; H A Clasener
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

7.  The in vitro inactivation of thirteen beta-lactam antibiotics by other mechanisms than adsorption to faecal substance.

Authors:  H de Vries-Hospers; G Jansen; R Tonk; D Oenema; D van der Waaij
Journal:  Infection       Date:  1993 Mar-Apr       Impact factor: 3.553

8.  Interference of Lactobacillus plantarum strains in the in vitro conjugative transfer of R-plasmids.

Authors:  Carla Sabia; Simona de Niederhäusern; Elisa Guerrieri; Moreno Bondi; Immacolata Anacarso; Ramona Iseppi; Patrizia Messi
Journal:  Curr Microbiol       Date:  2008-09-23       Impact factor: 2.188

9.  Effects of selective decontamination on gram-negative colonisation, infections and development of bacterial resistance in esophageal resection.

Authors:  G W Tetteroo; J H Wagenvoort; C Ince; H A Bruining
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

Review 10.  Colonization resistance of the human intestinal microflora: testing the hypothesis in normal volunteers.

Authors:  S L Gorbach; M Barza; M Giuliano; N V Jacobus
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-02       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.